Skip to main content

Shanghai's First Paralyzed Patient Controls Drinking with Brain Signals

Shanghai has reached a significant milestone in medical technology with the successful trial of a brain-machine interface, a breakthrough that could change the lives of paralyzed patients. On November 6, Huashan Hospital's neurosurgery department performed a pioneering clinical implantation of this innovative technology, which allows patients to regain some control over their movements using brain signals.

image

This state-of-the-art brain-machine interface was developed through a collaboration between Boruikang Medical Technology and Professor Hong Bo's team from Tsinghua University. The device allows paralyzed individuals to control external devices directly with their brain, bypassing the need for conventional physical input. The first patient to benefit from this technology, Xiao Dong, had been paralyzed for four years following an accident.

Unlike traditional brain-machine interfaces, which are invasive and often cause significant damage to brain tissue, this new system is designed to be minimally invasive. The device, about the size of a coin, is wireless and causes almost no harm to the brain. Remarkably, just one week after the surgery, Xiao Dong was discharged from the hospital, an indication of the technology's advanced design and minimal side effects.

The clinical trial, which was approved by the Huashan Hospital Ethics Committee, adhered to rigorous clinical trial standards for medical devices. It marked a significant leap forward in the potential for brain-machine interfaces to restore autonomy to those with severe disabilities. By November 15, Xiao Dong had already demonstrated the ability to control the action of drinking water with his brain signals, an achievement that many experts regard as a key milestone in the development of practical applications for brain-machine interfaces.

This groundbreaking advancement is seen as a major victory not only for medical technology but also for individuals living with physical disabilities. It opens new possibilities for rehabilitation and improved quality of life, offering renewed hope for those who had previously been unable to regain basic functions after paralysis.

The success of this clinical trial has garnered significant attention in the scientific community, with experts praising both the technological innovation and its potential societal impact. As the research progresses, it is expected that similar devices could become a standard part of treatment for individuals suffering from paralysis and other motor function disorders, paving the way for future breakthroughs in medical technology.

Key Points

  1. Shanghai's Huashan Hospital successfully completed a clinical trial of a brain-machine interface.
  2. The technology was developed by Boruikang Medical Technology and Tsinghua University’s Professor Hong Bo.
  3. The trial's first patient, Xiao Dong, was able to control drinking through brain signals just one week after surgery.
  4. The device is wireless, minimally invasive, and causes minimal damage to brain tissue, marking a significant advancement in medical technology.
  5. This breakthrough offers hope to millions of individuals with physical disabilities, potentially transforming rehabilitation treatments in the future.

Enjoyed this article?

Subscribe to our newsletter for the latest AI news, product reviews, and project recommendations delivered to your inbox weekly.

Weekly digestFree foreverUnsubscribe anytime

Related Articles

Health App Ant Afu Joins Forces With CCTV's Healthy Life Program
News

Health App Ant Afu Joins Forces With CCTV's Healthy Life Program

The AI-powered health application Ant Afu has partnered with CCTV's Healthy Life program, marking a significant step in digital healthcare accessibility. With over 10 million daily health inquiries processed, the app connects users to a network of 5,000 hospitals and 300,000 doctors nationwide. Notably, it features virtual consultations with top medical experts through its 'AI Avatars of Famous Doctors' program, bringing specialist care to remote areas.

February 10, 2026
digital healthAI healthcaretelemedicine
News

AI Boosts Breast Cancer Detection Rates in Major Swedish Trial

A landmark Swedish study involving 100,000 women reveals AI-assisted breast cancer screening reduces missed diagnoses by 12%. Published in The Lancet, the research shows AI detected 80% of cancers compared to radiologists' 74%, particularly excelling at spotting dangerous invasive cancers. While promising, experts caution these tools should support - not replace - doctors, and more studies are needed.

January 30, 2026
AI healthcarebreast cancer screeningmedical technology
News

Medical AI Startup OpenEvidence Hits $12B Valuation After $250M Funding Round

OpenEvidence, an AI platform revolutionizing how doctors access medical research, just secured $250 million in funding led by Thrive Capital and DST Global. The investment skyrockets the company's valuation to $12 billion - a tenfold increase since last year. Their ChatGPT-like tool helps physicians diagnose patients faster while staying current with medical literature, already serving over 100 million patients annually.

January 26, 2026
healthcare AImedical technologystartup funding
Claude AI Gets Medical License: A Game-Changer for Healthcare
News

Claude AI Gets Medical License: A Game-Changer for Healthcare

Anthropic's Claude AI has cleared a major hurdle by achieving HIPAA compliance, allowing it to handle sensitive health data legally. This breakthrough transforms Claude from a tech novelty into a practical tool for doctors and patients alike. Early adopters report significant efficiency gains, with the AI helping organize medical records, summarize research, and improve doctor-patient communication. Privacy remains paramount - Anthropic vows patient data will never be used for AI training.

January 13, 2026
AI in healthcareHIPAA compliancemedical technology
Chinese Brain Tech Firm Raises Whopping $280M, Challenges Musk's Neuralink
News

Chinese Brain Tech Firm Raises Whopping $280M, Challenges Musk's Neuralink

BrainCo, China's rising star in brain-computer interface tech, just landed a massive 2 billion yuan funding round - the country's largest yet in this cutting-edge field. Backed by heavyweight investors including Intel's CEO and Apple suppliers, the Harvard-born startup is accelerating its mission to bring non-invasive neural tech from labs to living rooms worldwide.

January 7, 2026
NeurotechnologyBrain-Computer InterfaceVenture Capital
News

Brain Tech Takes Off: How AI Is Revolutionizing Neurological Care

The brain-computer interface sector is heating up in 2026, with Neuralink's mass production announcement sending shockwaves through markets. Meanwhile, companies like Meiyuan Health are leveraging AI to transform brain health screening and care. Their 'NaoRuiJia' system combines MRI imaging with deep learning to detect neurological issues earlier than ever before. As China prioritizes brain science research and demand grows for preventive care, these innovations could reshape how we approach conditions like Alzheimer's and stroke.

January 6, 2026
Brain-Computer InterfaceAI HealthcareNeurological Innovation